Investments, Funding & Disinvestment

Under the agreement, Tanmeyah will provide tailored financing solutions for healthcare providers, particularly small and medium-sized facilities that often face constraints in investing in digital infrastructure.

The acquisition ranks among AbbVie’s largest transactions in recent years and reflects the company’s strategy to expand its next-generation immunology medicines as competition intensifies across the sector.

Mumbai-based Innovcare Lifesciences operates across the Indian market and focuses on marketing, distributing, and selling pharmaceutical products, nutraceuticals, and cosmeceuticals.

Under the agreement, Biogen will integrate RayThera’s portfolio of anti-inflammatory and immune-modulating candidates into its broader research and development engine.

The funding comes at a critical time, with health officials warning that the outbreak caused by the rare Bundibugyo strain of Ebola could become one of the most severe in history.

The Respiratory Summit 2026, held in London, brought together representatives from the asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and chronic rhinosinusitis communities for the first time under a shared prevention agenda.

The Commission argued that without the divestitures, the merged company could gain the ability to exert unilateral control over pricing in these markets.

The project forms part of the Kingdom’s broader efforts to strengthen mental health services while expanding private sector participation in healthcare delivery under the Health Sector Transformation Programme.

Novo Nordisk invested 3.5 billion Czech koruna (US$168 million) in modernisation works following its US$200 million acquisition of the facility.

The transaction concludes a phased investment strategy that steadily increased Amanat’s control over the group.